Medtronic has announced new, long-term data from the SPYRAL HTN-ON MED clinical trial that showed subjects who underwent radiofrequency renal denervation with the Symplicity Spyral renal denervation system had significantly greater reductions in 24-hr ambulatory systolic blood pressure, and office-based systolic blood pressure compared to sham patients at two years. The data were presented at […] The post TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation appeared first on Cardiovascular News .